Patents Assigned to New England Nuclear Corporation
-
Patent number: 4465676Abstract: 16.alpha.-Radiohalo-3,17.beta.-dihydroxy steroidal estrogens and their radiolabelled analogs are described. These steroidal estrogens have high estrogen receptor activity and are prepared by halogen exchange with the corresponding 16.beta.-bromo compound. The radiolabelled estrogens of this invention are useful in estrogen receptor assays, radioimmunoassays, in vivo imaging of tissue having estrogen receptor activity, and for therapeutic treatment of tumors having estrogen receptor activity.Type: GrantFiled: April 9, 1980Date of Patent: August 14, 1984Assignee: New England Nuclear CorporationInventor: Richard B. Hochberg
-
Patent number: 4455291Abstract: A composition for preparing cationic lipophilic technetium complexes is described. The composition comprises an admixture of (a) an accelerator compound selected from the group of water-soluble organic bidentate ligands that are capable of coordinating with technetium to form a 4 to 6 member ring and (b) a target-seeking ligand, or aqueous salt thereof, having the structure indicated in formulas I, II or III. The accelerator compound has a weaker coordinating bond with technetium than the target-seeking ligand has with technetium.Type: GrantFiled: January 22, 1982Date of Patent: June 19, 1984Assignee: New England Nuclear CorporationInventor: Michael F. Tweedle
-
Patent number: 4451450Abstract: A normally solid, hydrophilic compound capable of binding with Tc-99m to form a cationic complex is provided. The compound has a formula selected from: ##STR1## wherein: R, R', R", R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are each independently selected from hydrogen; or substituted or unsubstituted alkyl, alkylene, aryl, alkylaryl, arylalkyl, monocycloalkyl, polycycloalkyl, heterocyclic and carbocyclic groups; and R plus R.sup.i in formula (A) may be taken together to form a cyclic compound;A, A', A", A.sup.1, A.sup.2, A.sup.3, A.sup.4, A.sup.5 and A.sup.6 are independently neutral functional elements, each having a free electron pair available for accepting a proton to provide a charged ligand and having the capability of complexing with Tc-99m to form a cationic complex;Y.sup.1, Y.sup.2, Y.sup.3, Y.sup.4, Y.sup.5 and Y.sup.Type: GrantFiled: October 15, 1981Date of Patent: May 29, 1984Assignee: New England Nuclear CorporationInventor: Vinayakam Subramanyam
-
Patent number: 4432877Abstract: Compositions in which organo-mercurial moieties are bound to glass or other inorganic substrates are useful in separating sulfhydryl-containing compounds from mixtures with other compounds, e.g., by affinity chromatography.Type: GrantFiled: October 19, 1981Date of Patent: February 21, 1984Assignee: New England Nuclear CorporationInventor: Nathan R. Tzodikov
-
Patent number: 4429229Abstract: A method for producing various configurations of permanent magnet quadrupoles so that there is no coupling in the two transverse directions when focusing a charged particle beam is provided. Each configuration comprises a plurality of rotatable quadrupole disks, and means for rotating the quadrupole disks with respect to each other in a predetermined relationship.Type: GrantFiled: August 26, 1981Date of Patent: January 31, 1984Assignee: New England Nuclear CorporationInventor: Robert L. Gluckstern
-
Patent number: 4411881Abstract: A stabilized composition comprising a solution of a radiolabeled compound and a diethylenetriamine is described. Preferred diethylenetriamines include, N,N-bis(2-aminoethyl) dithiocarbamic acid, di(2-dithiocarbamyl-ethyl) amine, and salts thereof.Type: GrantFiled: July 12, 1982Date of Patent: October 25, 1983Assignee: New England Nuclear CorporationInventor: Nathan R. Tzodikov
-
Patent number: 4390517Abstract: A method of stabilizing a solution of a radiolabeled compound comprising adding to such solution a compound having a substantially insoluble backbone, to which has been bound a quaternary ammonium group; or a water soluble primary, secondary or tertiary aliphatic amine. The present invention also includes a solution of a radiolabeled compound maintained in contact with such a compound, and as an article of manufacture, a sealed vial containing such a solution.Type: GrantFiled: August 15, 1980Date of Patent: June 28, 1983Assignee: New England Nuclear CorporationInventors: Robert E. O'Brien, Nathan R. Tzodikov
-
Patent number: 4377075Abstract: A self-contained refrigerant package and method for shipment of a perishable or degradable product is described. The shipping package comprises an insulated container having therein a predetermined quantity of dry ice and a predetermined quantity of refrigerant gel that separates the product from the dry ice to prevent contact with the dry ice. The shipping package maintains the desired temperature range for periods in excess of 48 hours thus providing a safety factor for delays in shipment of such products.Type: GrantFiled: March 9, 1981Date of Patent: March 22, 1983Assignee: New England Nuclear CorporationInventor: Michael S. Russo
-
Patent number: 4358401Abstract: A liquid organic scintillation cocktail which is readily converted to a solid for disposal after use. Also disclosed are a method of disposal of radwaste employing the cocktail and a kit useful for practicing the method.Type: GrantFiled: March 31, 1980Date of Patent: November 9, 1982Assignee: New England Nuclear CorporationInventors: Robert E. O'Brien, Jeanne K. Krieger
-
Patent number: 4358434Abstract: A method and kit for stabilizing solutions of radiolabelled compound by the use of insoluble quaternary ammonium containing compounds. Also described are novel insoluble compounds having quaternary ammonium and sulfide groups for use in the present invention.Type: GrantFiled: December 19, 1979Date of Patent: November 9, 1982Assignee: New England Nuclear CorporationInventors: Nathan R. Tzodikov, Robert E. O'Brien
-
Patent number: 4355236Abstract: An adjustable strength multipole permanent magnet is disclosed that comprises a plurality of axial layers of magnetic material wherein one layer can be angularly displaced with respect to an adjacent layer, each of said axial layers comprising a plurality of segments comprising an oriented, anisotropic,, permanent magnet material arranged in a ring, each segment having a predetermined easy axis orientation that is preferably determined by the formula:.alpha.=2.theta.where .theta. is the angle between the radial symmetry line of a segment and the X-axis and .alpha. is the angle between said radial line and the easy axis of the segment.Type: GrantFiled: April 24, 1980Date of Patent: October 19, 1982Assignee: New England Nuclear CorporationInventor: Ronald F. Holsinger
-
Patent number: 4337240Abstract: Small sized material (less than 0.2 .mu.m, preferably less than 0.1 .mu.m) comprising a complex of (1) denatured albumin, particularly human serum albumin and (2) a metal reducing agent, particularly a stannous reducing agent, preferably formed in the presence of a stabilizing ligand, which complex, when labelled with technetium-99m provides an excellent agent for imaging or otherwise evaluating reticuloendothelial systems (RES) and/or components thereof, particularly the bone marrow, liver and/or lymphatic system; methods of making and using the same; a complex (physical or chemical) of technetium-99m with such materials and methods of using such latter complex.Type: GrantFiled: March 7, 1979Date of Patent: June 29, 1982Assignee: New England Nuclear CorporationInventor: Eugene L. Saklad
-
Patent number: 4330507Abstract: A method for generating Ga-68 from Ge-68 is provided that comprises contacting a substrate on which Ge-68 has been adsorbed with an alkaline solution having a pH of at least about 12 and thereby eluting Ga-68. Preferably the Ga-68 is eluted in the form of the gallate ion. A generator system comprises a generator column containing Ge-68 and Ga-68, a sealed eluant container having a predetermined quantity of eluant comprising an alkaline solution having a pH of at least about 12, and an evacuated eluate collection vial having a vacuum sufficient to draw the desired quantity of eluate into the eluate collection vial. The eluate collection vial can contain a neutralizing agent and also a diagnostically useful complexing agent.Type: GrantFiled: June 11, 1980Date of Patent: May 18, 1982Assignee: New England Nuclear CorporationInventor: Robert E. Lewis
-
Patent number: 4315906Abstract: A highly purified, biologically active cold insoluble globulin (CIG) preparation is provided having specific opsonic activity of at least 1000 units per mg of CIG. Methods of purifying CIG using affinity antibody columns are described in which the biological activity of the purified CIG is greater than 95% of the activity of the starting material.The purified CIG can be radiolabelled and radiopharmaceutical preparations containing such CIG are useful as scanning agents for in vivo localizing of areas where CIG-binding determinants are expressed. Such areas include thrombi and damaged tissue such as burns, heart, liver, spleen, muscle, skin, kidney and the like. These areas of localized radiolabelled CIG can be visualized with a gamma camera.Type: GrantFiled: May 21, 1979Date of Patent: February 16, 1982Assignee: New England Nuclear CorporationInventor: Frank B. Gelder
-
Patent number: 4293436Abstract: An improved method of enhancing the effect of weak, e.g. beta, radioactive emitters, such as tritium and carbon-14, on film by contacting the medium used to contain the radioactive emitter with a fluor dissolved or dispersed in a carboxylic acid.A new composition of matter for performing such a method, comprising a fluor dissolved or dispersed in a carboxylic acid.An article of manufacture comprising an aqueous separation medium impregnated with a fluor and a solvent.Type: GrantFiled: March 30, 1979Date of Patent: October 6, 1981Assignee: New England Nuclear CorporationInventor: Dennis L. Fost
-
Patent number: 4278653Abstract: Methods and kits for performing a double antibody immunoassay are described. The immunoassay comprises:reacting an antigen and a labelled version of said antigen with a first antibody against said antigen and said first antibody with a second antibody against said first antibody to precipitate a complex of said antigen, said first antibody and said second antibody, andprecipitating a colored protein to form a precipitate comprised of said complex and colored protein.In a preferred embodiment, the first and second antibodies can be prereacted to simplify the assay procedure.Type: GrantFiled: February 1, 1979Date of Patent: July 14, 1981Assignee: New England Nuclear CorporationInventors: S. Richard Harris, Darlene K. Bonci
-
Patent number: 4272503Abstract: Reductant compositions for reducing technetium to produce technetium labelled ligands comprise a substrate having attached thereto a reducing complex having sufficient redox potential to reduce technetium from the +7 oxidation state. Preferably the reducing complex comprises a reducing agent for technetium and a chelating ligand therefor. Technetium labelled ligands are prepared by mixing such ligands with pertechnetate in the presence of the reductant of this invention and separating the reductant from the resulting labelled ligand. Technetium labelled ligands that are substantially free from reducing agent used in their preparation may be made in this manner.Type: GrantFiled: May 25, 1978Date of Patent: June 9, 1981Assignee: New England Nuclear CorporationInventors: Leopoldo L. Camin, Maria P. Liteplo
-
Patent number: 4226846Abstract: Microaggregates of a complex of (1) albumin, particularly human serum albumin and (2) a metal reducing agent, particularly a stannous reducing agent, preferably formed in the presence of a stabilizing ligand, which complex, when labelled with technetium-99m provides an excellent agent for imaging reticuloendothelial systems (RES), particularly the liver, spleen, and bone marrow; methods of making and using the same; a complex (physical or chemical) of technetium-99m with such microaggregates and methods of using such latter complex.Type: GrantFiled: April 20, 1978Date of Patent: October 7, 1980Assignee: New England Nuclear CorporationInventor: Eugene L. Saklad
-
Patent number: 4136159Abstract: Novel folic acid derivatives useful in processes for analysis of biological fluids for folic acid or its metabolites comprising components of the formula: ##STR1## wherein R is hydrogen or radioactive iodine.Type: GrantFiled: February 28, 1977Date of Patent: January 23, 1979Assignee: New England Nuclear CorporationInventor: Marcia J. Stone
-
Patent number: 4124527Abstract: Liquid scintillation counting compositions which include certain polyethoxylated poly(oxypropylene) emulsifiers allow stable dispersion of aqueous or other samples merely by shaking. Preferred are mixtures of such emulsifiers, which give homogeneous, monophasic-appearing dispersions over wide ranges of temperature and aqueous sample content. Certain of these emulsifiers, without being mixed, are of particular advantage when used in analysis of samples obtained through radioimmunoassay techniques, which are extremely difficult to disperse. Certain of these emulsifiers, also without being mixed, uniformly give homogeneous, monophasic appearing aqueous counting samples over much wider ranges of aqueous sample content and temperature than prior sample emulsifiers.Type: GrantFiled: December 15, 1975Date of Patent: November 7, 1978Assignee: New England Nuclear CorporationInventor: Joel M. Kauffman